Sign In
COVID-19: A question-based discussion on treatment
ESCMID eLearning. Jesús Rodríguez-Baño, Annelies Zinkernagel, Maurizio Sanguinetti, Jose R. Arribas, Antonella D'Arminio Monforte . 05/28/20; 303294
 Jesús Rodríguez-Baño, Annelies Zinkernagel, Maurizio Sanguinetti, Jose R. Arribas, Antonella D'Arminio Monforte
Jesús Rodríguez-Baño, Annelies Zinkernagel, Maurizio Sanguinetti, Jose R. Arribas, Antonella D'Arminio Monforte
Contributions
About this activity
This webinar is Open-Access (no login required) and was hosted on May 28 2020 18:00 - 19:00 CEST (GMT: 16:00 - 17:00).

WEBINAR OUTLINE
18:00-18:05 Welcome and Introduction Jesús Rodríguez-Baño (Hospital Universitario Virgen Macarena, Seville, Spain)
Moderators:
Jesús Rodríguez-Baño (Hospital Universitario Virgen Macarena, Seville, Spain)
Annelies Zinkernagel (Universitätsspital Zürich, Switzerland)
Maurizio Sanguinetti (Università Cattolica del Sacro Cuore, Rome, Italy)

18:05-18:25 Jose R. Arribas (Hospital La Paz, Madrid, Spain)
1. Which criteria would you use to hospitalise a patient with a positive PCR for SARS-CoV-2?
2. What antiviral treatment (if any) would you provide to a patient admitted with COVID-19 pneumonia? What variables would you consider for your decision?

18:25-18:35 Q&A
18:35-18:55 Antonella D'Arminio Monforte (University of Milan, Italy)
3. How would you follow-up COVID-19 patients? Which clinical data and laboratory tests would you do and with what frequency?
4. Would you consider the use of anti-inflammatory/immunosuppressive drugs? Which ones? In which situations/patients?

18:55-19:05 Q&A
​19:05-19:10 Conclusions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies